M3
VC Fund
Tokyo, Japan
M3 is a VC fund in Tokyo focused on Health Care and Biotechnology. M3 provides healthcare professionals to improve the efficiency of the medical field.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 19%
- Fund size:
- $93M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries M3 invests in
Stages M3 invests in
Countries M3 invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $2.5M–$40M
- Corporate Round
- $881k–$42M
- Venture - Series Unknown
- $2M–$9M
Investment Focus
Industry
- Health Care 15 (56%)
- Biotechnology 6 (22%)
- Medical 5 (19%)
- Nursing and Residential Care 5 (19%)
- Pharmaceutical 4 (15%)
Stage
- Series B 6 (22%)
- Venture - Series Unknown 6 (22%)
- Corporate Round 5 (19%)
- Seed 3 (11%)
- Series A 3 (11%)
Country
- Japan 18 (67%)
- Nigeria 3 (11%)
- Egypt 1 (4%)
- Ghana 1 (4%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brian Hooper
CTO
|
CTO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| VALT JAPAN is a social business compan that continues to pursue solutions to social issues. | $2.5M / Series B / Jan 09, 2024 | ||
| Chefaa is a GPS-enabled pharmacy benefits platform connecting patients & pharmacies nation-wide to help patients manage all their pharmacy needs. Chefaa uses big data, data ming & machine learning | $5.3M / Seed / Dec 17, 2023 | ||
| Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $5.2M / Seed / Nov 14, 2022 | ||
| Africa Health Holdings cultivates a work-environment that motivates professionals to strive to exceed their expectations. It offers a variety of exciting and challenging careers across Africa and North America. It values teamwork and the enthusiasm to become a contributor to the development and success of local communities across Africa.It wasfounded in 2017 and is headquartered in Accra, Ghana with offices in Nigeria and New York. | $10M / Convertible Note / May 17, 2022 | ||
| RelianceHMO is solving this problem by providing affordable and reliable insurance packages for the average African. Reliance makes health insurance in Africa cheaper and easier to access by combining Telemedicine with data science. | $40M / Series B / Feb 07, 2022 | ||
| Reliance Health is a healthcare company using technology to make healthcare more affordable and accessible. Using an integrated approach that includes affordable health insurance, telemedicine, and a combination of partner and proprietary healthcare facilities. | $40M / Series B / Feb 01, 2022 | ||
| Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics. | Series A / Jan 31, 2022 | ||
| Carepoint Hospitals is a network of healthcare facilities providing optimized and patient-centered services. | $18M / Series A / Nov 16, 2021 | ||
| Africa Health Holdings cultivates a work-environment that motivates professionals to strive to exceed their expectations. It offers a variety of exciting and challenging careers across Africa and North America. It values teamwork and the enthusiasm to become a contributor to the development and success of local communities across Africa.It wasfounded in 2017 and is headquartered in Accra, Ghana with offices in Nigeria and New York. | $18M / Series A / Nov 15, 2021 | ||
| Epigno provides hospital management systems for medical institutions. | $2.2M / Corporate Round / Jul 01, 2021 | ||
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does M3 invest in?
M3 invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Venture - Series Unknown stage. Most of the 27 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is M3's check size?
M3 typically joins rounds of $2.5M–$40M at Series B, $881k–$42M at Corporate Round and $2M–$9M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds M3 participates in.
How do I contact M3?
Public channels for M3 include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at M3?
The team at M3 includes Brian Hooper (CTO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
